Exclusive preview: Sanofi, Ipsen and Gilead reveal trends in patient centricity
There’s never been a more exciting time to work in patient engagement. Patient centricity is the buzzword of the industry – but it’s up to us to ensure it becomes more than that, embedding patient value at the heart of pharma’s model.
To that end, eyeforpharma spoke to leaders from Sanofi, Ipsen, Gilead, Viiv Healthcare and others to discover what they see as the biggest opportunities in patient engagement today.
Read the full magazine here - http://bit.ly/PatientCentricityTrends
Covered in our magazine:
• The six ways pharma can use AI to positively impact patients
• How pharma can reduce the effects of stigma and enhance the patient experience
• The evolution of the Chief Patient Officer role in championing the patient voice internally
Download your copy for free here - http://bit.ly/PatientCentricityTrends
To that end, eyeforpharma spoke to leaders from Sanofi, Ipsen, Gilead, Viiv Healthcare and others to discover what they see as the biggest opportunities in patient engagement today.
Read the full magazine here - http://bit.ly/PatientCentricityTrends
Covered in our magazine:
• The six ways pharma can use AI to positively impact patients
• How pharma can reduce the effects of stigma and enhance the patient experience
• The evolution of the Chief Patient Officer role in championing the patient voice internally
Download your copy for free here - http://bit.ly/PatientCentricityTrends